The Algorithm of Us

Chapter 57: The New Company

The morning after the kiss, Claire found Ethan already at the borrowed office, three whiteboards covered in a diagram that looked less like a company and more like an argument.

"Fourteen," he said, tapping the marker against the board. "That's how many people I've called who told me, in one way or another, that you can't run an algorithm study without the algorithm."

"Of course you can't."

"Right. So we stop pretending we're a study group and become something that owns its own IP." He stepped back. "A nonprofit. We build our own version—same architecture, clean training data, gender variables locked in from the first line of code."

Claire set down her coffee and walked the boards. He'd scrawled *CardioSense Alliance* across the top of one, then crossed it out, then written it again.

"CardioSense is a Helix trademark," she said.

"I know. Placeholder."

"Then we need a real name by Thursday."

"Thursday?"

"Because Deborah's data monitoring committee meets Friday, and Sarah's IRB submission needs an institutional sponsor on the cover page, and a nonprofit with no legal name can't sponsor a cardboard box." She pulled the marker from his hand and wrote beneath his scribble: *Bramble Center for Device Equity.*

Ethan looked at it for a long moment. "Halloway's daughter's name was Bramble?"

"Her married name. Constance asked us to use it. She said the money wasn't a donation, it was a memorial, and memorials get to have names."

He picked up the eraser, then set it back down and left it alone.

They drafted the bylaws at a corner table at the café downstairs, because the borrowed office had two chairs and one of them wobbled. Claire typed; Ethan argued with her about every third line.

"Seven board seats," she said.

"Five."

"Seven. Two patient advisors, two clinical, two scientific, one community. It's in the grant terms."

"Then it's not a board, it's a summit."

"It's a governance structure that can't be captured by one institution." She kept typing. "That's the entire point."

He conceded with a tilt of his head and stole her cold coffee.

The hard part was the IP opinion. Their outside counsel—a Boston firm doing the work at a discount after the review board report made them look good—delivered it Tuesday: the algorithm's core methods were patented by Helix, but the *validation methodology* and the retrained gender-stratified model were arguably new work, and "arguably" was a litigator's word, not an engineer's.

"Meaning what, in English," Claire said on the call.

"Meaning you can publish and you can run the study," the lawyer said. "Meaning if the merger closes and Vanterra inherits the portfolio, they will send you a letter. Probably a long one."

"How long do we have?"

"To build the thing? Six weeks to the proxy vote. To fight the letter? Years."

Claire hung up and looked at Ethan.

"We already knew that," he said.

"I know."

"Then why do you look like someone just told you."

"Because the letter isn't the risk," she said. "The risk is they use the letter to spook Deborah's committee."

He was quiet. Then: "So we stop treating the committee like a jury and start treating it like a board."

She understood him before he finished the sentence. "We put the committee people on the board."

"We put *everyone* on something. Sarah. Maria. Deborah. Halloway as a trustee. A patient seat we fill from the advisory group."

Claire pulled up the consent forms. "I asked forty-one people for permission to use their outcomes data. Eleven said yes. That's not a board seat, that's a target."

"Then start with the two PIs Maria sent us."

Maria said yes in a text that consisted of one word and no punctuation, which from her was a paragraph.

Sarah said yes in person, in the hallway outside the lab, and then immediately made it complicated.

"I'll do it," she said, arms crossed, "if I'm not the token. I want the data monitoring charter. I want to write the stopping rules, and I want them written so the trial stops if there's harm, not if there's *inconvenience*."

"That's the whole job."

"Then say it back to me."

Claire said it back to her. Sarah uncrossed her arms.

"The IRB submission's drafted," Sarah added. "I rewrote the consent language. Your old version buried the gender-flag disclosure in paragraph nine. Nobody reads paragraph nine."

"Helix wrote that version."

"I know. I read it at 2 a.m. and wanted to throw my laptop out the window."

They got the two remaining PIs on a Thursday call—Providence and a site in New Mexico, both dropped by Helix in the same quarter, both run by women who had spent eighteen months documenting every anomalous read. The Providence PI, Dr. Okafor, asked one question: "Who owns the data?"

"The Bramble Center," Claire said. "Not the sponsor. Not a company. The center, with the committee able to publish regardless of result."

There was a pause long enough that Claire checked whether the call had dropped.

"Then we're in," Okafor said. "Both of us."

The last domino was the name. *Bramble* tested clean, no marks, no conflicts. Constance Halloway sent a note that was three sentences long and made Claire read it twice: *My daughter spent four years being told her symptoms were anxiety. Use the name. Make it mean something different.*

Ethan read it over her shoulder and didn't say anything, which was how she knew it had landed.

They filed the incorporation papers on a Wednesday. Massachusetts nonprofit, purpose clause: *to conduct independent clinical validation of medical device algorithms and to publish all results.*

"No carve-outs," Ethan had insisted. "Nothing we can be bought out of."

"Nothing we can be bought out of," she'd typed.

The 501(c)(3) determination would take months. The bank account took a week. The $1.4 million moved on a Friday afternoon, and Claire watched the balance appear on a screen in the borrowed office and felt, absurdly, like she'd stolen something.

The first official board meeting was the following Monday, in a conference room at the medical institute that Sarah had talked someone into donating—six chairs, a table with a water ring already on it, a whiteboard whose markers were all dry except one.

They were seven: Claire as executive director; Ethan as scientific lead; Sarah as director of data monitoring; Maria as director of community engagement, a title she'd negotiated down from "outreach" on the grounds that outreach was what you did to people, not with them; Dr. Okafor and the New Mexico PI, Dr. Reyes, as site directors; and Ruth Delgado, sixty-four, pacemaker since 2019, the first patient advisor to sign the consent forms and the only person in the room who had been on the receiving end of the algorithm.

"Quorum," Claire said, and everyone laughed because there was no reason to.

They went through the agenda the way new organizations do—slowly, over-explaining things to each other, discovering in real time which assumptions had been load-bearing. Maria wanted the meeting minutes public within seventy-two hours. Okafor wanted a data safety charter before the first enrollment, not after. Reyes wanted enrollment to start at her site, not Boston, because Boston was where the story lived and she wanted the science to live somewhere else.

Ethan, who had spent the entire meeting listening with his pen capped, finally uncapped it.

"One more thing," he said. "The protocol says we validate on consented retrospective data first. I want a public registry entry before we touch a single record. Date-stamped, so when the subpoenas come, the timeline isn't ours to argue about."

Sarah nodded slowly. "That's smart. That's also going to make them come faster."

"Yes," Ethan said.

Claire looked around the table. Six faces, none of them neutral, all of them people who had already paid something to be here. Somewhere upstairs a hospital was running a different algorithm on a different woman and calling her anxious.

"Then let's vote," she said. "All in favor of going fast."

Seven hands went up.

The last marker squeaked on the whiteboard as Maria wrote the enrollment dates, and outside the window the light was doing that Boston-in-spring thing, oversaturated and brief.

"We should celebrate," Ruth said. "My granddaughter says you celebrate the first meeting, because after that it's work."

Claire was about to answer when her phone buzzed against the table. She glanced down, expecting Sarah with an IRB question or Deborah with a committee name.

It was a number she didn't have saved, and the message was four words long: *I know what Kessler did.*

She turned the phone face down before Ethan could see it.

Back to book

Sign in or create an account

Sign in with Google to keep your library and reading progress on every device.

Continue with Google

By continuing you agree to our Terms and Privacy.

Chapter 57: The New Company · The Algorithm of Us · Lumen Reads